SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-000370
Filing Date
2020-01-09
Accepted
2020-01-09 08:24:27
Documents
24
Period of Report
2020-01-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200108_8k.htm 8-K 22689
2 INVESTOR PRESENTATION ex_169051.htm EX-99.1 12775
3 a01.jpg GRAPHIC 55261
4 a02.jpg GRAPHIC 165717
5 a03.jpg GRAPHIC 110027
6 a04.jpg GRAPHIC 94441
7 a05.jpg GRAPHIC 80144
8 a06.jpg GRAPHIC 56794
9 a07.jpg GRAPHIC 73500
10 a08.jpg GRAPHIC 87137
11 a09.jpg GRAPHIC 64981
12 a10.jpg GRAPHIC 89472
13 a11.jpg GRAPHIC 60212
14 a12.jpg GRAPHIC 79301
15 a13.jpg GRAPHIC 94186
16 a14.jpg GRAPHIC 90420
17 a15.jpg GRAPHIC 81173
18 a16.jpg GRAPHIC 127504
19 a17.jpg GRAPHIC 74201
20 a18.jpg GRAPHIC 103731
21 a19.jpg GRAPHIC 91173
22 a20.jpg GRAPHIC 94366
23 a21.jpg GRAPHIC 86688
24 a22.jpg GRAPHIC 37921
  Complete submission text file 0001437749-20-000370.txt   2653175
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20517069
SIC: 2834 Pharmaceutical Preparations